PT2552440T - Nova combinação e uso - Google Patents
Nova combinação e usoInfo
- Publication number
- PT2552440T PT2552440T PT11714379T PT11714379T PT2552440T PT 2552440 T PT2552440 T PT 2552440T PT 11714379 T PT11714379 T PT 11714379T PT 11714379 T PT11714379 T PT 11714379T PT 2552440 T PT2552440 T PT 2552440T
- Authority
- PT
- Portugal
- Prior art keywords
- new combination
- new
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1005318.9A GB201005318D0 (en) | 2010-03-30 | 2010-03-30 | Novel combination |
| GBGB1013211.6A GB201013211D0 (en) | 2010-08-05 | 2010-08-05 | Novel combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2552440T true PT2552440T (pt) | 2019-01-10 |
Family
ID=43982400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT11714379T PT2552440T (pt) | 2010-03-30 | 2011-03-29 | Nova combinação e uso |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9789101B2 (pt) |
| EP (1) | EP2552440B1 (pt) |
| JP (1) | JP5932762B2 (pt) |
| KR (1) | KR20130065649A (pt) |
| CN (1) | CN102933212B (pt) |
| AU (1) | AU2011234219A1 (pt) |
| BR (1) | BR112012024999A2 (pt) |
| CA (1) | CA2794570C (pt) |
| DK (1) | DK2552440T3 (pt) |
| ES (1) | ES2703253T3 (pt) |
| HR (1) | HRP20182083T1 (pt) |
| HU (1) | HUE041512T2 (pt) |
| MX (1) | MX2012011236A (pt) |
| PL (1) | PL2552440T3 (pt) |
| PT (1) | PT2552440T (pt) |
| RU (1) | RU2012146093A (pt) |
| SI (1) | SI2552440T1 (pt) |
| WO (1) | WO2011121345A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2976756A1 (en) * | 2015-02-26 | 2016-09-01 | Limited Liability Company "Konsortsium-Pik" | Pharmaceutical composition for treatment of inflammatory ear diseases, method for producing same and method for treatment using said composition |
| GB201518969D0 (en) * | 2015-10-27 | 2015-12-09 | Helperby Therapeutics Ltd | Triple combination |
| EP3703686A4 (en) * | 2017-10-30 | 2021-11-17 | Theracaine LLC | HYDROPHOBIC ARENE SULFONATE SALTS |
| KR102461715B1 (ko) * | 2020-10-12 | 2022-11-02 | 대한민국 | 항균 및 항진균 활성을 나타내는 신균주 페니실리움 비세티 및 이의 용도 |
| CN115643955B (zh) * | 2022-11-06 | 2024-04-26 | 华中农业大学 | 阿霉素在抑制植物病原菌中的应用 |
| CN116083290B (zh) * | 2022-11-21 | 2024-06-14 | 陕西省微生物研究所 | 一种铅锌和/或抗生素和/或抗性基因污染土壤修复的复合微生物菌剂及其应用 |
| US11926627B1 (en) | 2023-08-30 | 2024-03-12 | King Faisal University | Substituted 7-methyl quinoline derivatives as antitubercular agents |
| CN119656167B (zh) * | 2024-09-30 | 2025-09-05 | 天津大学 | 2-氨基喹啉在制备抑制鼠伤寒沙门氏菌药物的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB843133A (en) * | 1957-07-16 | 1960-08-04 | Biorex Laboratories Ltd | Glycyrrhetinic acid derivatives |
| US4808410A (en) * | 1987-12-16 | 1989-02-28 | Richardson-Vicks Inc. | Pharmaceutical compositions containing dyclonine HC1 and phenol |
| IL95952A0 (en) * | 1989-10-19 | 1991-07-18 | Sterling Drug Inc | Aerosol composition for topical medicament |
| CA2024220A1 (en) * | 1990-08-29 | 1992-03-01 | Don Simmons | Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery |
| GB9026873D0 (en) * | 1990-12-11 | 1991-01-30 | Beecham Group Plc | Novel compounds |
| CN1102410C (zh) | 1993-10-22 | 2003-03-05 | 史密丝克莱恩比彻姆公司 | 莫匹罗星钙盐的乳膏组合物 |
| ES2229780T3 (es) | 1998-11-09 | 2005-04-16 | Helperby Therapeutics Limited | Procesos de muestreo para identificacion de agentes antibacterianos. |
| PT1395289E (pt) * | 2000-06-08 | 2011-03-16 | Sang Dr Christine | Tratamento da dor neuropática com antagonistas do receptor de n-metil-d-aspartato (nmda) |
| US6974585B2 (en) | 2001-08-01 | 2005-12-13 | Medlogic Global Limited | Durable multi-component antibiotic formulation for topical use |
| JP3876232B2 (ja) * | 2003-04-18 | 2007-01-31 | 有限会社ユーワ商事 | 眼科用製剤、点眼液、人工涙液、コンタクトレンズケアー用品、洗眼液、および眼軟膏 |
| EP1660486A4 (en) | 2003-08-08 | 2006-12-13 | Ulysses Pharmaceutical Product | HALOGENATED CHINAZOLINYL NITROFURANES AS ANTIBACTERIAL AGENTS |
| EP1766768B1 (en) * | 2004-05-13 | 2012-07-11 | University Of Virginia Patent Foundation | Use of lacritin in promoting ocular cell survival |
| KR20070091613A (ko) | 2004-11-08 | 2007-09-11 | 그렌마크 파머수티칼스 엘티디. | 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물 |
| GB0522715D0 (en) * | 2005-11-08 | 2005-12-14 | Helperby Therapeutics Ltd | New use |
| US7767217B2 (en) * | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
| GB0705915D0 (en) | 2007-03-28 | 2007-05-09 | Helperby Therapeutics Ltd | New use |
| WO2008142384A1 (en) * | 2007-05-17 | 2008-11-27 | Helperby Therapeutics Limited | Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms |
| US9248093B2 (en) * | 2009-06-11 | 2016-02-02 | Becton, Dickinson And Company | Catheter locking solution having antimicrobial and anticoagulation properties |
-
2011
- 2011-03-29 HU HUE11714379A patent/HUE041512T2/hu unknown
- 2011-03-29 PT PT11714379T patent/PT2552440T/pt unknown
- 2011-03-29 AU AU2011234219A patent/AU2011234219A1/en not_active Abandoned
- 2011-03-29 DK DK11714379.2T patent/DK2552440T3/en active
- 2011-03-29 EP EP11714379.2A patent/EP2552440B1/en not_active Not-in-force
- 2011-03-29 BR BR112012024999A patent/BR112012024999A2/pt not_active IP Right Cessation
- 2011-03-29 MX MX2012011236A patent/MX2012011236A/es not_active Application Discontinuation
- 2011-03-29 ES ES11714379T patent/ES2703253T3/es active Active
- 2011-03-29 RU RU2012146093/15A patent/RU2012146093A/ru not_active Application Discontinuation
- 2011-03-29 CA CA2794570A patent/CA2794570C/en not_active Expired - Fee Related
- 2011-03-29 JP JP2013501944A patent/JP5932762B2/ja not_active Expired - Fee Related
- 2011-03-29 KR KR1020127028381A patent/KR20130065649A/ko not_active Withdrawn
- 2011-03-29 US US13/624,488 patent/US9789101B2/en not_active Expired - Fee Related
- 2011-03-29 HR HRP20182083TT patent/HRP20182083T1/hr unknown
- 2011-03-29 PL PL11714379T patent/PL2552440T3/pl unknown
- 2011-03-29 CN CN201180026672.4A patent/CN102933212B/zh not_active Expired - Fee Related
- 2011-03-29 SI SI201131637T patent/SI2552440T1/sl unknown
- 2011-03-29 WO PCT/GB2011/050641 patent/WO2011121345A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2552440A1 (en) | 2013-02-06 |
| EP2552440B1 (en) | 2018-10-10 |
| DK2552440T3 (en) | 2019-01-21 |
| RU2012146093A (ru) | 2014-05-10 |
| CA2794570A1 (en) | 2011-10-06 |
| BR112012024999A2 (pt) | 2016-07-12 |
| ES2703253T3 (es) | 2019-03-07 |
| HRP20182083T1 (hr) | 2019-03-08 |
| JP5932762B2 (ja) | 2016-06-15 |
| CA2794570C (en) | 2018-03-06 |
| CN102933212A (zh) | 2013-02-13 |
| KR20130065649A (ko) | 2013-06-19 |
| SI2552440T1 (sl) | 2019-03-29 |
| PL2552440T3 (pl) | 2019-04-30 |
| AU2011234219A1 (en) | 2012-10-18 |
| JP2013523707A (ja) | 2013-06-17 |
| US9789101B2 (en) | 2017-10-17 |
| MX2012011236A (es) | 2013-03-05 |
| CN102933212B (zh) | 2015-07-22 |
| HUE041512T2 (hu) | 2019-05-28 |
| WO2011121345A1 (en) | 2011-10-06 |
| US20130096151A1 (en) | 2013-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2021021I2 (el) | Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους | |
| BR112013007506A2 (pt) | piridinonas/pirazinonas - métodos de criação e de uso | |
| BR112013010988A2 (pt) | composição fluída e uso | |
| BRPI1012533A2 (pt) | composto de piradazinona e uso do mesmo | |
| BR112012002349A2 (pt) | composto,e, uso do mesmo | |
| BR112012031232A2 (pt) | método, dispositivo e uso | |
| SMT201500291B (it) | Nuovi agenti antimalarici | |
| BR112012017441A2 (pt) | compostos e métodos | |
| PL2627295T3 (pl) | Struktura chłonna | |
| BRPI1007494A2 (pt) | composto e uso do mesmo | |
| BR112013014119A2 (pt) | novos moduladores e métodos de uso | |
| IL221511A (en) | Arilatriazolones associated with bis aryl and their use | |
| ZA201208173B (en) | Peptices and their use | |
| HRP20171579T8 (hr) | Antigljivična sredstva i njihova upotreba | |
| BR112013006016A2 (pt) | compostos de azabenzotiazol, composições e métodos de uso | |
| HRP20160922T1 (hr) | Oligopeptidni spojevi i njihove uporabe | |
| HRP20170936T1 (hr) | Alkilamido spojevi i njihova uporaba | |
| CO6781486A2 (es) | Compuestos y su uso | |
| BRPI1011036A2 (pt) | uso | |
| FR2957073B1 (fr) | Beton ultraleger et son utilisation | |
| CR20140362A (es) | Fenilimidazopirazoles sustituidos y su uso | |
| HRP20182083T1 (hr) | Nova kombinacija i uporaba | |
| BR112013013551A2 (pt) | composto e uso médico do mesmo | |
| BR112013012175A2 (pt) | combinação, coadministração, uso e método | |
| BRPI1013597A2 (pt) | seringa para uso único |